このアイテムのアクセス数: 83
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
j.stemcr.2024.10.006.pdf | 214.04 kB | Adobe PDF | 見る/開く |
完全メタデータレコード
DCフィールド | 値 | 言語 |
---|---|---|
dc.contributor.author | Ikka, Tsunakuni | en |
dc.contributor.author | Hatta, Taichi | en |
dc.contributor.author | Fujita, Misao | en |
dc.contributor.alternative | 藤田, みさお | ja |
dc.date.accessioned | 2024-12-17T06:38:16Z | - |
dc.date.available | 2024-12-17T06:38:16Z | - |
dc.date.issued | 2024-12-10 | - |
dc.identifier.uri | http://hdl.handle.net/2433/290903 | - |
dc.description.abstract | The key amendment to the Act on the Safety of Regenerative Medicine in June 2024 is regarding on-site inspections and the criteria for disqualifying the Certified Special Committees for Regenerative Medicine and Certified Committees for Regenerative Medicine. Appropriate regulations are needed after the legal amendment to stop the widespread use of unproven interventions and move away from the concept of a “Therapeutic Haven.” | en |
dc.language.iso | eng | - |
dc.publisher | Elsevier BV | en |
dc.publisher | International Society for Stem Cell Research | en |
dc.rights | © 2024 The Author(s). Published by Elsevier Inc. on behalf of International Society for Stem Cell Research. | en |
dc.rights | This is an open access article under the CC BY-NC-ND license. | en |
dc.rights.uri | https://creativecommons.org/licenses/by-nc-nd/4.0/ | - |
dc.title | Amendments to ASRM: Can we move away from a “Therapeutic Haven”? | en |
dc.type | journal article | - |
dc.type.niitype | Journal Article | - |
dc.identifier.jtitle | Stem Cell Reports | en |
dc.identifier.volume | 19 | - |
dc.identifier.issue | 12 | - |
dc.identifier.spage | 1648 | - |
dc.identifier.epage | 1650 | - |
dc.relation.doi | 10.1016/j.stemcr.2024.10.006 | - |
dc.textversion | publisher | - |
dc.identifier.pmid | 39547227 | - |
dcterms.accessRights | open access | - |
dc.identifier.eissn | 2213-6711 | - |
出現コレクション: | 学術雑誌掲載論文等 |

このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス